miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5

Table 3

Correlation between miR-370-3p in breast cancer serum and clinicopathological parameters.

Clinicopathological information	n	Relative expression of miR-370-3p	P
Tumor diameter
<=2cm	16	0.136(0.058, 0.268)	0.0513
>2cm	11	0.377(0.161, 0.481)
Age
<=50	7	0.130(0.054, 0.197)	0.1530
>50	20	0.264(0.093, 0.444)
Pathological type
Ductal carcinoma in situ	2	0.079(0.027, 0.102)	0.6287
Invasive ductal carcinoma	9	0.281(0.138, 0.348)
Invasive cancer	13	0.168(0.091, 0.327)
Others	3	0.364(0.264, 0.481)
Lymph node metastasis
0	18	0.149(0.040, 0.281)	0.0168
>=1	9	0.480(0.143, 0.651)
TNM staging
I	14	0.136(0.040, 0.268)	0.0308
II	13	0.377(0.138, 0.508)